AzTrials
AzTrials

AI-assisted DocumentationNCT06836258

Effect of AI Assisted Documentation in Primary Health Care on Time Saving, Patient Satisfaction and Health Care Provider Satisfaction

A study testing AI assisted documentation in people with AI-assisted Documentation, run by Helsinki University Central Hospital at 1 site in Finland.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Background There is currently no research evidence from randomized trial settings on the effectiveness of AI-assisted documentation. The aim of this study is to provide evidence regarding cost-effectiveness, professional experience, and patient experience. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
AI-assisted Documentation
What is being tested?
AI assisted documentation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteFinland
Study dates
1 Mar 2025to Nov 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Clinician practices at a site in Western Uusimaa wellbeing services county where AI-assisted documentation tool is available

Who cannot join

  • none
  • The study will include all acute and non-acute visits for the enrolled clinician. The study excludes sector-specific work and specialized consultations, such as maternity clinics, memory clinics, intellectual disability consultations, as well as non-Finnish-language consultations and interpreter-assisted consultations. The system has been primarily designed to monitor discussions between two individuals, and therefore, consultations where a guardian or companion accompanies the patient are also excluded from the study.

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • Western Uusimaa Welbeing services county

    Espoo, Nummela, Kirkkonummi

Other trials in Finland

About this study

Official title: A Randomized Clinical Trial on the Effectiveness of AI-Assisted Documentation

Background There is currently no research evidence from randomized trial settings on the effectiveness of AI-assisted documentation. The aim of this study is to provide evidence regarding cost-effectiveness, professional experience, and patient experience.

Design Physician consultations participating in the study are randomized into AI-assisted and traditional documentation groups in a 1:1 repeated crossover design. The goal is to include approximately 1,000 consultations per group.

Methods Professionals will be asked to provide their own assessment of potential time savings, and the time spent on documentation will be measured using technical data from the documentation tools (cost-effectiveness). Additionally, professionals will complete baseline and follow-up surveys (professional experience), and patients will be sent a survey following the consultation (patient experience).

Read the detailed description

The study will include all acute and non-acute visits for the enrolled clinician. The study excludes sector-specific work and specialized consultations, such as maternity clinics, memory clinics, intellectual disability consultations, as well as non-Finnish-language consultations and interpreter-assisted consultations. The system has been primarily designed to monitor discussions between two individuals, and therefore, consultations where a guardian or companion accompanies the patient are also excluded from the study.

Being tested
AI assisted documentation
Keywords
AI, documentation, Effectiveness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI assisted documentationOther

    This study will use Gosta Aide AI-assisted documentation platform

Study groups in NCT06836258
Study groupRoleWhat they receive
AI-assisted documentation vs regular documentationOtherAll subjects (clinicians) will be in a single arm. However, appointmets of each clinican will be randomized into AI-assisted and traditional documentation groups in 1:1.
Receives: Other: AI assisted documentation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time saved using AI-assisted documentation

    The documentation platform will measure time used for documentation of the appointment for both AI-assisted and regular documentation. For each appointment separately, from the moment the patient leaves the appointment until the documentation is finished and saved to the patient records.

    Measured: From enrollment until the of study (approx two months).

Secondary outcomes (7)
  1. Subjective time saving in documentation due to AI-assisted documentation

    Each clinician will give their subjective assessment the time saved or wasted due to AI tool per appointment (in minutes) after each day through study completion (approximately two months).

    Measured: Assessed once a day after the days appointments and records have been completed through study completion, expected 2 months..

  2. Clinician satisfaction questionnaire

    Clinicans will report their satisfaction by assessing the effect of AI tool to quality of documentation. The questionnaire includes three questions answered in 1-5 likert scale where 1 worst and 5 best outcome. The questions are "How has AI affected time used in documentation?" (1 = IIncreased the time spent on documentation significantly, 5 = Decreased the time spent on documentation significantly) "How has AI affected the quality of documentation?" (1 = Decreased the quality of documentation significantly, 5 = Increased the quality of documentation significantly) "How has AI affected patient safety?" (1 = Significantly compromised patient safety, 5 = Significantly improved patient safety)

    Measured: At the end of the study (expected two months)

  3. Clinician satisfaction by Net Promotor Score (NPS)

    Clinicans will report their satisfaction (regarding AI tool) by NPS. The question is stated "Would you recommend AI assisted documentation to your colleague?" and is assessed in scale 0-10 where 0 means would not recommend and 10 is would recommend extremely highly.

    Measured: At the end of the study (expected two months)

  4. Clinician satisfaction by willingness to continue with the tool

    Clinicans will report their satisfaction by assessing whether they would like to continue with the AI-tool or using regular method. The question is stated "In future, would you prefer to do clinical documentation with the now used AI-based tool or as you were doing previously without the AI-based tool?" (With AI-tool/Without AI-tool)

    Measured: At the end of the study (expected two months)

  5. Patient satisfaction by Net Promotor Score (NPS)

    Patient satisfaction will be assessed after each appointemnt using NPS. The patients who visit a participating clinician will receive a questionnaire including NPS once after each of their appointment. The scale is 0-10 where 0 is would not recommend the appointment at all and 10 would highly recommend the appointment.

    Measured: Immediately after the randomized appointment

  6. Patient satisfaction by Patient Enablement Instrument (PEI)

    Patient satisfaction will be assessed after each appointemnt using PEI questionnaire. The patients who visit a participating clinician will receive a questionnaire including PEI once after each of their appointment. Score ranges between 0-12 and higher score indicates better outcome for the patient.

    Measured: Immediately after the randomized appointment

  7. Patient satisfaction by The Patient Satisfaction Questionnaire Short Form (PSQ-18)

    Patient satisfaction will be assessed after each appointment using PSQ18 questionnaire. The patients who visit a participating clinician will receive a questionnaire including PSQ18 once after each of their appointment. Score ranges from 18 to 90 and higher score indicates worse patient experience.

    Measured: Immediately after the randomized appointment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2025
  2. Study start1 Mar 2025
  3. Primary completionSep 2025 (estimated)
  4. Study completionNov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Crossover
Model description
Single-arm repeated crossover design
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06836258
Sponsor's protocol ID
GA-RCT-1
Status last verified
Jan 2025
First submitted
22 Jan 2025
Last updated
14 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data contains sensitive information and cannot be shared due to Finnish research legislation

Questions about this trial

What is this clinical trial studying?

A study testing AI assisted documentation in people with AI-assisted Documentation, run by Helsinki University Central Hospital at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 14 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time saved using AI-assisted documentation (time frame: From enrollment until the of study (approx two months).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in